HEADER TOXIN 25-AUG-99 1CW6 TITLE REFINED SOLUTION STRUCTURE OF LEUCOCIN A COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYPE IIA BACTERIOCIN LEUCOCIN A; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: LEUCOCIN A-UAL 187 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: LEUCONOSTOC GELIDUM; SOURCE 3 ORGANISM_TAXID: 1244 KEYWDS ANTIMICROBIAL PEPTIDE, BACTERIOCIN, TOXIN EXPDTA SOLUTION NMR NUMMDL 18 AUTHOR Y.WANG,M.E.HENZ,N.L.F.GALLAGHER,S.CHAI,L.Z.YAN,A.C.GIBBS, AUTHOR 2 M.E.STILES,D.S.WISHART,J.C.VEDERAS REVDAT 4 24-FEB-09 1CW6 1 VERSN REVDAT 3 01-APR-03 1CW6 1 JRNL REVDAT 2 02-APR-00 1CW6 1 JRNL REMARK REVDAT 1 08-SEP-99 1CW6 0 JRNL AUTH Y.WANG,M.E.HENZ,N.L.GALLAGHER,S.CHAI,A.C.GIBBS, JRNL AUTH 2 L.Z.YAN,M.E.STILES,D.S.WISHART,J.C.VEDERAS JRNL TITL SOLUTION STRUCTURE OF CARNOBACTERIOCIN B2 AND JRNL TITL 2 IMPLICATIONS FOR STRUCTURE-ACTIVITY RELATIONSHIPS JRNL TITL 3 AMONG TYPE IIA BACTERIOCINS FROM LACTIC ACID JRNL TITL 4 BACTERIA. JRNL REF BIOCHEMISTRY V. 38 15438 1999 JRNL REFN ISSN 0006-2960 JRNL PMID 10569926 JRNL DOI 10.1021/BI991351X REMARK 1 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.85 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: THE REFINED STRUCTURES ARE BASED ON REMARK 3 A TOTAL OF 434 INTERPROTON DISTANCE RESTRAINTS, 27 3JHNHA REMARK 3 COUPLING CONSTANT RESTRAINTS, AND 136 PROTON CHEMICAL SHIFT REMARK 3 RESTRAINTS REMARK 4 REMARK 4 1CW6 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 26-AUG-99. REMARK 100 THE RCSB ID CODE IS RCSB009583. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 2.8 REMARK 210 IONIC STRENGTH : 0 REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 2MM LEUCOCIN A IN 90% TFE-D3, REMARK 210 10% H2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 500 MHZ REMARK 210 SPECTROMETER MODEL : UNITY REMARK 210 SPECTROMETER MANUFACTURER : VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : X-PLOR 3.85, VNMR 5.1 REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 18 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 18 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH ACCEPTABLE REMARK 210 COVALENT GEOMETRY,STRUCTURES REMARK 210 WITH FAVORABLE NON- BOND REMARK 210 ENERGY,STRUCTURES WITH THE REMARK 210 LEAST RESTRAINT VIOLATIONS, REMARK 210 STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 9 REMARK 210 REMARK 210 REMARK: THIS STRUCTURE WAS DETERMINED USING STANDARD 2D REMARK 210 HOMONUCLEAR TECHNIQUES. THE STRUCTURE WAS DETERMINED USING REMARK 210 TRIPLE-RESONANCE NMR SPECTROSCOPY. REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 TYR A 3 40.34 -109.73 REMARK 500 1 ASN A 5 52.42 -145.80 REMARK 500 1 LYS A 11 34.77 36.10 REMARK 500 1 SER A 12 47.00 74.04 REMARK 500 1 TRP A 18 -65.14 64.07 REMARK 500 1 ASN A 34 -61.12 66.11 REMARK 500 1 PHE A 36 80.77 55.64 REMARK 500 2 TYR A 3 41.17 -103.26 REMARK 500 2 ASN A 5 39.69 -148.14 REMARK 500 2 LYS A 11 -61.46 22.55 REMARK 500 2 TRP A 18 -70.49 65.55 REMARK 500 3 LYS A 11 -84.27 77.73 REMARK 500 3 SER A 12 22.68 -153.44 REMARK 500 3 TRP A 18 -60.71 65.90 REMARK 500 3 PHE A 36 -155.83 72.29 REMARK 500 4 ASN A 5 38.94 -148.01 REMARK 500 4 CYS A 9 78.21 -119.39 REMARK 500 4 LYS A 11 -89.68 83.21 REMARK 500 4 SER A 12 20.79 -149.61 REMARK 500 4 TRP A 18 -64.93 17.21 REMARK 500 4 PHE A 36 112.22 77.42 REMARK 500 5 ASN A 5 33.25 -146.98 REMARK 500 5 LYS A 11 -85.38 87.57 REMARK 500 5 SER A 12 31.89 -150.49 REMARK 500 5 TRP A 18 -69.02 19.51 REMARK 500 5 ASN A 34 -46.86 -150.93 REMARK 500 5 PHE A 36 35.43 -162.21 REMARK 500 6 TYR A 3 42.20 -105.77 REMARK 500 6 ASN A 5 29.66 -146.47 REMARK 500 6 TRP A 18 -59.47 70.17 REMARK 500 7 ASN A 5 50.71 -107.55 REMARK 500 7 CYS A 9 79.21 -114.16 REMARK 500 7 LYS A 11 -87.26 83.05 REMARK 500 7 SER A 12 22.63 -150.92 REMARK 500 7 TRP A 18 -63.25 64.94 REMARK 500 7 ASN A 34 46.15 -152.22 REMARK 500 8 TYR A 3 40.53 -106.06 REMARK 500 8 ASN A 5 48.17 -147.91 REMARK 500 8 CYS A 9 65.24 -113.23 REMARK 500 8 LYS A 11 101.32 29.11 REMARK 500 8 SER A 12 -46.48 82.02 REMARK 500 8 TRP A 18 -63.43 62.41 REMARK 500 9 ASN A 5 45.95 -146.48 REMARK 500 9 TRP A 18 -64.94 66.31 REMARK 500 9 PHE A 36 45.39 -163.12 REMARK 500 10 ASN A 5 33.57 -146.48 REMARK 500 10 LYS A 11 -85.88 92.42 REMARK 500 10 SER A 12 26.50 -151.44 REMARK 500 10 TRP A 18 -63.92 68.26 REMARK 500 10 PHE A 36 -1.11 76.59 REMARK 500 11 ASN A 5 48.14 -148.89 REMARK 500 11 LYS A 11 -66.42 47.08 REMARK 500 11 SER A 12 17.08 -154.59 REMARK 500 11 TRP A 18 -69.58 66.24 REMARK 500 12 ASN A 5 47.48 -148.11 REMARK 500 12 TRP A 18 -62.61 66.96 REMARK 500 12 ASN A 34 -68.43 -98.14 REMARK 500 13 TYR A 3 -31.71 -132.55 REMARK 500 13 ASN A 5 49.97 -101.34 REMARK 500 13 TRP A 18 -60.82 68.63 REMARK 500 13 PHE A 36 117.59 -161.69 REMARK 500 14 ASN A 5 49.21 -146.36 REMARK 500 14 CYS A 9 75.97 -106.99 REMARK 500 14 LYS A 11 -87.96 85.59 REMARK 500 14 SER A 12 21.80 -152.06 REMARK 500 14 TRP A 18 -62.54 68.16 REMARK 500 14 ALA A 30 -78.66 -79.31 REMARK 500 14 ASN A 31 71.60 43.96 REMARK 500 14 PHE A 36 33.61 -161.94 REMARK 500 15 ASN A 5 40.83 -145.54 REMARK 500 15 TRP A 18 -64.85 65.47 REMARK 500 16 ASN A 5 32.18 -147.06 REMARK 500 16 CYS A 9 77.81 -116.09 REMARK 500 16 LYS A 11 35.04 39.40 REMARK 500 16 SER A 12 33.02 73.39 REMARK 500 16 TRP A 18 -66.27 68.26 REMARK 500 16 ASN A 34 -42.37 -152.06 REMARK 500 16 PHE A 36 70.87 -161.06 REMARK 500 17 ASN A 5 36.61 -146.82 REMARK 500 17 LYS A 11 -54.44 25.08 REMARK 500 17 TRP A 18 -59.73 67.82 REMARK 500 17 ASN A 34 76.95 45.33 REMARK 500 17 PHE A 36 -78.85 -163.31 REMARK 500 18 ASN A 5 33.99 -145.22 REMARK 500 18 CYS A 9 78.10 -106.11 REMARK 500 18 LYS A 11 -85.09 37.27 REMARK 500 18 SER A 12 21.31 -149.30 REMARK 500 18 TRP A 18 -68.92 74.86 REMARK 500 18 ASN A 34 95.76 53.74 REMARK 500 18 PHE A 36 173.56 50.67 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2LEU RELATED DB: PDB REMARK 900 2LEU CONTAINS THE SAME PEPTIDE WITH A STRUCTURE BASED ON REMARK 900 FEWER CONTRAINTS. DBREF 1CW6 A 1 37 UNP P34034 LCCA_LEUGE 25 61 SEQRES 1 A 37 LYS TYR TYR GLY ASN GLY VAL HIS CYS THR LYS SER GLY SEQRES 2 A 37 CYS SER VAL ASN TRP GLY GLU ALA PHE SER ALA GLY VAL SEQRES 3 A 37 HIS ARG LEU ALA ASN GLY GLY ASN GLY PHE TRP HELIX 1 1 TRP A 18 ALA A 30 1 13 SHEET 1 A 2 HIS A 8 THR A 10 0 SHEET 2 A 2 GLY A 13 SER A 15 -1 O GLY A 13 N THR A 10 SSBOND 1 CYS A 9 CYS A 14 1555 1555 2.03 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL MASTER 169 0 0 1 2 0 0 6 0 0 0 3 END